Most Recent Articles about EC
Celgene Gets EC Nod for Label Expansion of Revlimid, Imnovid May 17, 2019 - Celgene (CELG) obtains approval for the label expansion of oncology drugs Revlimid and Imnovid in Europe.
Here's Why You Should Invest in Hess (HES) Stock Right Now May 17, 2019 - Focus on prolific onshore and offshore resources is likely to back Hess' (HES) oil equivalent productions.
New Strong Buy Stocks for May 17th May 17, 2019 - New Strong Buy Stocks for May 17th

Related Companies

Name Exchange Price Mkt Cap
OXY Occidental Petroleum Corporation NYSE $77.6 $59.34B
CNQ Canadian Natural Resources Limited NYSE $31.6 $38.59B
EOG EOG Resources, Inc. NYSE $117.54 $68.08B
E ENI S.p.A. NYSE $37.64 $68.4B
PBR Petroleo Brasileiro S.A.- Petrobras NYSE $10.92 $71.22B
Sector: Energy > Industry: Oil & Gas Production